Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
about
Living donor liver transplantation in EuropeLiving donor liver transplantation in the USAComplications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort StudyDefining long-term outcomes with living donor liver transplantation in North AmericaChanges in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.Superior survival using living donors and donor-recipient matching using a novel living donor risk index.Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis.Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.HLA-G polymorphism (rs16375) and acute rejection in liver transplant recipients.Living Donor Liver Transplant is a Transparent Activity in India.Is there an advantage of living over deceased donation in liver transplantation?Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis.Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient.Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?Longterm clinical and radiological follow-up of living liver donors.Clinical Impacts of Donor Types of Living vs. Deceased Donors: Predictors of One-Year Mortality in Patients with Liver Transplantation.Racial and ethnic disparities in access to and utilization of living donor liver transplants.Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.Recipient factors associated with having a potential living donor for liver transplantation.Fully laparoscopic left-sided donor hepatectomy is safe and associated with shorter hospital stay and earlier return to work: A comparative study.[Living liver donor: indications and technical aspects].Early Graft Dysfunction in Living Donor Liver Transplantation and the Small for Size Syndrome.Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.Benefit of living donor liver transplantation: who and when?Death of a living liver donor: opening Pandora's box.Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.[Liver transplantation with living donor : current aspects, perspectives and significance in Germany].Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching.Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.Palliative care in decompensated cirrhosis: A review.
P2860
Q26749724-8E0190A4-C66F-45B0-82C0-763D5D577004Q26749806-01D0F010-BCBD-40B0-8F4C-B25B1F3E6F71Q30354315-4E85F736-B9A2-4D03-9A0F-61E1EB785765Q30356729-768C9E38-49ED-43A3-B404-03DCAD702C97Q30361159-10811CAF-3C9E-451D-A697-E6CDC67814AFQ30406052-877662FE-3F91-44E4-9760-F9172FD7415AQ30416480-BF0076D9-21DE-4172-B2C5-0258E13DB06EQ31164899-092771F9-4F6F-464E-A862-4AFF8E145039Q34415850-079D31C8-2DAC-488F-AC72-DEE639E42E57Q34576123-6E0BFA58-42A4-4286-AA43-6BA4D0DC0733Q35869964-5F4A71B6-8AEB-48CD-9356-133B76D586B9Q36922088-210C9CF0-A549-44CB-86D3-0130DD31B022Q37088965-8EF7EADC-7400-4AE8-8785-BABF2BC4E7B1Q37090275-AD324FF5-E7A8-4827-B9A2-ED5B1B36E1DBQ37586726-8E1994DA-0ECD-4E8F-9369-5198DA7DEF41Q37613137-E14F7199-E20B-4DCB-A778-F38A8F523B38Q38039451-16140CDE-EB5A-44B2-9BB5-9499E93B7BD3Q38060208-6CC7673B-D404-4888-BF2A-55FCD1A3B71DQ38085291-1566FCFB-3C52-4055-8787-5A624DE77345Q38183336-D7DDB391-2012-4A2F-96C2-B03F976F2773Q38757577-BCF6BD8C-AF93-4CDF-8DAF-A4C4EA9AE686Q38871759-257CA6FF-9F37-478B-B580-46ADC6036F61Q40152475-FFA49691-B63D-46B8-9463-373612EA13DEQ40271644-E1D70953-3862-4415-B902-9624A9DE1444Q40638450-9FCB9762-2165-40BD-A9E0-97AA807E2370Q40945206-B208AC00-22BC-45BD-B05E-C1614A638665Q41043788-E270C662-2E13-465C-94E9-316A87B52564Q41194020-8DBFB585-B243-4A2A-BE88-F7A538D6DFCCQ41714218-BC7AF405-C412-4911-B321-20FAFAF67160Q41817590-7D8AC668-B8B4-462D-968D-46C81344D120Q43560509-9E1A28EB-94BB-4764-8FD2-EED7EA32C378Q43940787-1098D904-3B6D-4447-BFB7-6E2841FDF267Q43942493-36147958-C711-4026-A3F3-0DF6EEAD39B1Q44720190-F6AB573A-E018-43FE-9D9A-BDAD62D6C6F3Q45059270-077D6E6D-287B-4AEB-8CD7-4F8603DF1D57Q46040254-CB8E7902-6915-4979-8917-74D80C96C243Q47108565-B79D36D9-B36D-4A55-A8F8-72A323CCA448Q47961983-BE0CF9EC-A2B1-400E-AE67-EEC8AE513D86Q48160957-D04B25C4-236D-412B-82CB-6E666502E2E8Q48349992-90269F98-40DF-486F-B83F-72F03A6521E6
P2860
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Liver transplant recipient sur ...... liver disease allocation era.
@ast
Liver transplant recipient sur ...... liver disease allocation era.
@en
type
label
Liver transplant recipient sur ...... liver disease allocation era.
@ast
Liver transplant recipient sur ...... liver disease allocation era.
@en
prefLabel
Liver transplant recipient sur ...... liver disease allocation era.
@ast
Liver transplant recipient sur ...... liver disease allocation era.
@en
P2093
P2860
P356
P1433
P1476
Liver transplant recipient sur ...... liver disease allocation era.
@en
P2093
Carl L Berg
Gregory T Everson
James E Everhart
Johnny C Hong
Kim M Olthoff
Norah Terrault
Paul H Hayashi
Robert A Fisher
Robert M Merion
Robert S Brown
P2860
P304
P356
10.1002/HEP.24494
P407
P577
2011-10-01T00:00:00Z